Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

KOCHI: Let’s start with the basics. How important is water for health? What’s the role of the kidneys in water balance?Water ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

ASX small-cap shares are slightly outperforming the broader market in 2025. Here are four stocks that brokers recommend to ...

An England-wide study of 331 rare diseases in over 58 million people co-led by UCL researchers has identified eight rare ...

for APOL1-mediated kidney disease, in phase 3, and early-stage candidate VX-407 for autosomal dominant polycystic kidney disease. Bank of America analysts said in a research note that the deal ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...

Several risk tools can accurately predict individual baseline risks of adverse events in people with chronic kidney disease. Here, the authors examine methods of assessing risk and discuss risk ...

Over the more than 50 years since the floating of the US dollar, American economists have broadly agreed with US former Treasury Secretary Connolly’s 1971 message to the rest of the world: “It’s our ...

We're dedicated to conducting cutting-edge, fundamental basic and translational research to improve human health and educating the next generation of scientists. Our faculty, staff, and trainees play ...